Innovis Asset Management’s Tarsus Pharmaceuticals TARS Stock Holding History

Innovis Asset Management’s Portfolio TARS Stock Details TARS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-13,141	Closed	-$237K	–	178
2023 Q2	$237K	Buy	13,141 +82	+0.6%	+$1.3K	0.09%	140
2023 Q1	$164K	Buy	13,059 +78	+0.6%	+$1.14K	0.07%	151
2022 Q4	$190K	Buy	+12,981	New	+$215K	0.09%	138

Other funds holding TARS

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Cormorant Asset Management Boston, Massachusetts $1.98B AUM 737.95% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Cowen and Company New York $2.9B AUM 105.26% 1-Year Est. Return

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return